Are there any recent discoveries in stem cell research?

Researchers Discover Key Stem Cell Dormancy Mechanism Which Could Help Unlock Future Cancer Treatments. Aug. 3, 2021 — Researchers have made new findings which provide a broader understanding of how dormant hematopoietic stem cells are activated and could pave the way …

What is the current risk with stem cell research?

The risks to research participants undergoing stem cell transplantation include tumour formation, inappropriate stem cell migration, immune rejection of transplanted stem cells, haemorrhage during neurosurgery and postoperative infection.

What are stem cell scientists investigating today?

Scientists are investigating how stem cells form tissues and organs, how aging impacts their function and their role in various diseases and conditions. A better understanding of the inner working of living organisms leads to earlier detection, better diagnosis and more effective treatments for diseases and injury.

What is the current status of stem cell therapy?

In regenerative medicine, stem cells are currently considered ideal candidates for the treatment of diseases and injuries of the nervous system, for which, at present, there are no effective treatments.

What is the stem cell banking market trend?

Stem Cell Banking Market Trend for Development and marketing channels are analysed. Finally, the feasibility of new investment projects is assessed and overall research conclusions offered. Stem Cell Banking Market Report also mentions market share accrued by each product in the Stem Cell Banking market, along with the production growth.

How is stem cell medicine used to treat autism?

Stem Cell Medicine’s technology for the treatment of autism is based on stem cell-derived exosomes delivered through the intranasal route.Cases of ASDs in children have been on the rise in the recent past.To date, there is no effective treatment for this spectrum of disorders.

Are there any cell therapy products for multiple sclerosis?

This is a biotechnology company focused on developing second-generation cell therapy products designed to address neurological indications, such as multiple sclerosis, pain, and neuromuscular injuries.In 2019, they rolled out a study to investigate the potential of exosomes in treating autistic spectrum disorders (ASD).